Advances with glucocorticoids in the treatment of asthma: state of the art

References

• Magiakou MA, Chrousos GP. Cushing’s syndrome in children and adolescents: current diagnostic and therapeutic strategies. J Endocrinol Invest. 2002;25(2):181–194.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Adcock IM. How do corticosteroids work in asthma? Ann Intern Med. 2003;139(5 Pt 1):359–370.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. How corticosteroids control inflammation: quintiles prize lecture 2005. Br J Pharmacol. 2006;148(3):245–254.
   PubMed Web of Science ®Google Scholar
• Reddel HK, Bateman ED, Becker A, et al. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J. 2015;46(3):622–639.
   PubMed Web of Science ®Google Scholar
• GINA Report. Global Strategy for Asthma Management and Prevention. Published online 2019. Available from: https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf
   Google Scholar
• Adcock IM, Mumby S. Glucocorticoids. Handb Exp Pharmacol. 2017;237:171–196.
   PubMedGoogle Scholar
• O’Byrne PM, FitzGerald JM, Bateman ED, et al. Inhaled combined budesonide-formoterol as needed in mild asthma. N Engl J Med. 2018;378(20):1865–1876.
   PubMed Web of Science ®Google Scholar
• Dunican EM, Fahy JV. Asthma and corticosteroids: time for a more precise approach to treatment. Eur Respir J. 2017;49(6):1701167.
   PubMed Web of Science ®Google Scholar
• Schäcke H, Döcke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002;96(1):23–43.
   PubMed Web of Science ®Google Scholar
• Kadmiel M, Cidlowski JA. Glucocorticoid receptor signaling in health and disease. Trends Pharmacol Sci. 2013;34(9):518–530.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Glucocorticosteroids. Handb Exp Pharmacol. 2017;237:93–115.
   PubMedGoogle Scholar
• Pujols L, Mullol J, Picado C. Alpha and beta glucocorticoid receptors: relevance in airway diseases. Curr Allergy Asthma Rep. 2007;7(2):93–99.
   PubMed Web of Science ®Google Scholar
• Ito K, Barnes PJ, Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol. 2000;20(18):6891–6903.
   PubMed Web of Science ®Google Scholar
• Ito K, Getting SJ, Charron CE. Mode of glucocorticoid actions in airway disease. ScientificWorldJournal. 2006;6:1750–1769.
   PubMed Web of Science ®Google Scholar
• Ito K, Caramori G, Lim S, et al. Expression and activity of histone deacetylases in human asthmatic airways. Am J Respir Crit Care Med. 2002;166(3):392–396.
   PubMed Web of Science ®Google Scholar
• Bhavsar P, Hew M, Khorasani N, et al. Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma. Thorax. 2008;63(9):784–790.
   PubMed Web of Science ®Google Scholar
• Adenuga D, Caito S, Yao H, et al. Nrf2 deficiency influences susceptibility to steroid resistance via HDAC2 reduction. Biochem Biophys Res Commun. 2010;403(3–4):452–456.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Histone deacetylase-2 and airway disease. Ther Adv Respir Dis. 2009;3(5):235–243.
   PubMedGoogle Scholar
• Barnes PJ. Corticosteroids: the drugs to beat. Eur J Pharmacol. 2006;533(1–3):2–14.
   PubMed Web of Science ®Google Scholar
• Bergmann MW, Staples KJ, Smith SJ, et al. Glucocorticoid inhibition of granulocyte macrophage-colony-stimulating factor from T cells is independent of control by nuclear factor-kappaB and conserved lymphokine element 0. Am J Respir Cell Mol Biol. 2004;30(4):555–563.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Corticosteroids I. atopy. J Clin Invest. 2001;107(3):265–266.
   PubMed Web of Science ®Google Scholar
• Brostjan C, Anrather J, Csizmadia V, et al. Glucocorticoids inhibit E-selectin expression by targeting NF-kappaB and not ATF/c-Jun. J Immunol. 1997;158(8):3836–3844.
   PubMed Web of Science ®Google Scholar
• Westergaard CG, Porsbjerg C, Backer V. Emerging corticosteroid agonists for the treatment of asthma. Expert Opin Emerg Drugs. 2015;20(4):653–662.
   PubMed Web of Science ®Google Scholar
• Pelaia G, Vatrella A, Busceti MT, et al. Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthma. Pulm Pharmacol Ther. 2016;40:15–21.
   PubMed Web of Science ®Google Scholar
• Gauvreau GM, Doctor J, Watson RM, et al. Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med. 1996;154(5):1267–1271.
   PubMed Web of Science ®Google Scholar
• Druilhe A, Létuvé S, Pretolani M. Glucocorticoid-induced apoptosis in human eosinophils: mechanisms of action. Apoptosis. 2003;8(5):481–495.
   PubMed Web of Science ®Google Scholar
• Schleimer RP, Bochner BS. The effects of glucocorticoids on human eosinophils. J Allergy Clin Immunol. 1994;94(6 Pt 2):1202–1213.
   PubMed Web of Science ®Google Scholar
• Rogliani P, Matera MG, Facciolo F, et al. Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: synergy of triple combination therapy on human airway smooth muscle ex vivo. Br J Pharmacol. Published online 2019 October 29. DOI:10.1111/bph.14909
   Web of Science ®Google Scholar
• Cazzola M, Calzetta L, Rogliani P, et al. Interaction between corticosteroids and muscarinic antagonists in human airways. Pulm Pharmacol Ther. 2016;36:1–9.
   PubMed Web of Science ®Google Scholar
• Mager DE, Lin SX, Blum RA, et al. Dose equivalency evaluation of major corticosteroids: pharmacokinetics and cell trafficking and cortisol dynamics. J Clin Pharmacol. 2003;43(11):1216–1227.
   PubMed Web of Science ®Google Scholar
• Daley-Yates PT. Inhaled corticosteroids: potency, dose equivalence and therapeutic index. Br J Clin Pharmacol. 2015;80(3):372–380.
   PubMed Web of Science ®Google Scholar
• Chung KF, Caramori G, Adcock IM. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. Eur J Clin Pharmacol. 2009;65(9):853–871.
   PubMed Web of Science ®Google Scholar
• Derendorf H, Nave R, Drollmann A, et al. Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. Eur Respir J. 2006;28(5):1042–1050.
   PubMed Web of Science ®Google Scholar
• Tamm M, Richards DH, Beghé B, et al. Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice. Respir Med. 2012;106(Suppl 1):S9–19.
   PubMed Web of Science ®Google Scholar
• Nave R, Fisher R, McCracken N. In vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in human lung precision-cut tissue slices. Respir Res. 2007;8:65.
   PubMed Web of Science ®Google Scholar
• Valotis A, Högger P. Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate. Respir Res. 2007;8:54.
   PubMed Web of Science ®Google Scholar
• Lange P, Scharling H, Ulrik CS, et al. Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax. 2006;61(2):100–104.
   PubMed Web of Science ®Google Scholar
• Cohen J, Postma DS, Douma WR, et al. Particle size matters: diagnostics and treatment of small airways involvement in asthma. Eur Respir J. 2011;37(3):532–540.
   PubMed Web of Science ®Google Scholar
• Levy ML, Thomas M, Small I, et al. Summary of the 2008 BTS/SIGN British guideline on the management of asthma. Prim Care Respir J. 2009;18(Suppl 1):S1–16.
   PubMedGoogle Scholar
• O’Byrne PM, Jenkins C, Bateman ED. The paradoxes of asthma management: time for a new approach? Eur Respir J. 2017;50(3). DOI:10.1183/13993003.01103-2017
   PubMed Web of Science ®Google Scholar
• Calzetta L, Matera MG, Facciolo F, et al. Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways. Respir Res. 2018;19(1):65.
   PubMed Web of Science ®Google Scholar
• Papi A, Canonica GW, Maestrelli P, et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med. 2007;356(20):2040–2052.
   PubMed Web of Science ®Google Scholar
• Bateman ED, Reddel HK, O’Byrne PM, et al. As-needed budesonide-formoterol versus maintenance budesonide in mild asthma. N Engl J Med. 2018;378(20):1877–1887.
   PubMed Web of Science ®Google Scholar
• Beasley R, Holliday M, Reddel HK, et al. Controlled trial of budesonide-formoterol as needed for mild asthma. N Engl J Med. 2019;380(21):2020–2030.
   PubMed Web of Science ®Google Scholar
• Rogliani P, Ritondo BL, Ora J, et al. SMART and as-needed therapies in mild to severe asthma: a network meta-analysis. Eur Respir J. Published online 2020 May 19:2000625. DOI:10.1183/13993003.00625-2020
   PubMed Web of Science ®Google Scholar
• Reddel HK, Busse WW, Pedersen S, et al. Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study. Lancet. 2017;389(10065):157–166.
   PubMed Web of Science ®Google Scholar
• Lazarus SC, Krishnan JA, King TS, et al. Mometasone or tiotropium in mild asthma with a low sputum eosinophil level. N Engl J Med. 2019;380(21):2009–2019.
   PubMed Web of Science ®Google Scholar
• Schleich FN, Seidel L, Sele J, et al. Exhaled nitric oxide thresholds associated with a sputum eosinophil count ≥3% in a cohort of unselected patients with asthma. Thorax. 2010;65(12):1039–1044.
   PubMed Web of Science ®Google Scholar
• Schleich F, Brusselle G, Louis R, et al. Heterogeneity of phenotypes in severe asthmatics. the Belgian severe asthma registry (BSAR). Respir Med. 2014;108(12):1723–1732.
   PubMed Web of Science ®Google Scholar
• Truong-Thanh T, Vo-Thi-Kim A, Vu-Minh T, et al. The beneficial role of FeNO in association with GINA guidelines for titration of inhaled corticosteroids in adult asthma: A randomized study. Adv Med Sci. 2020;65(2):244–251.
   PubMed Web of Science ®Google Scholar
• Petsky HL, Kynaston JA, Turner C, et al. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev. 2007;(2):CD005603. DOI:10.1002/14651858.CD005603.pub2
   PubMed Web of Science ®Google Scholar
• Wang G, Zhang X, Zhang HP, et al. Corticosteroid plus β2-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis. Respir Res. 2017;18(1):203.
   PubMed Web of Science ®Google Scholar
• Hanratty CE, Matthews JG, Arron JR, et al. A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial. Trials. 2018;19(1):5.
   PubMed Web of Science ®Google Scholar
• Berthon BS, Gibson PG, Wood LG, et al. A sputum gene expression signature predicts oral corticosteroid response in asthma. Eur Respir J. 2017;49:6.
   Web of Science ®Google Scholar
• Pazdrak K, Moon Y, Straub C, et al. Eosinophil resistance to glucocorticoid-induced apoptosis is mediated by the transcription factor NFIL3. Apoptosis. 2016;21(4):421–431.
   PubMed Web of Science ®Google Scholar
• Jones AM, Munavvar M, Vail A, et al. Prospective, placebo-controlled trial of 5 vs 10 days of oral prednisolone in acute adult asthma. Respir Med. 2002;96(11):950–954.
   PubMed Web of Science ®Google Scholar
• Kew KM, Quinn M, Quon BS, et al. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. Cochrane Database of Systematic Reviews. Cochrane Airways Group, ed; 2016. Published online 2016 June 7. DOI:10.1002/14651858.CD007524.pub4
   Google Scholar
• Jayaram L, Pizzichini MM, Cook RJ, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J. 2006;27(3):483–494.
   PubMed Web of Science ®Google Scholar
• McCracken JL, Veeranki SP, Ameredes BT, et al. Diagnosis and management of asthma in adults: a review. JAMA. 2017;318(3):279–290.
   PubMed Web of Science ®Google Scholar
• Kayani S, Shannon DC. Adverse behavioral effects of treatment for acute exacerbation of asthma in children: a comparison of two doses of oral steroids. Chest. 2002;122(2):624–628.
   PubMed Web of Science ®Google Scholar
• Normansell R, Kew KM, Mansour G. Different oral corticosteroid regimens for acute asthma. Cochrane Database Syst Rev. 2016;5:CD011801. DOI:10.1002/14651858.CD011801.pub2
   PubMed Web of Science ®Google Scholar
• Lederle FA, Pluhar RE, Joseph AM, et al. Tapering of corticosteroid therapy following exacerbation of asthma. A randomized, double-blind, placebo-controlled trial. Arch Intern Med. 1987;147(12):2201–2203.
   PubMedGoogle Scholar
• Sweeney J, Patterson CC, Menzies-Gow A, et al. Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the optimum patient care research database and the british thoracic difficult asthma registry. Thorax. 2016;71(4):339–346.
   PubMed Web of Science ®Google Scholar
• Molimard M, Buhl R, Niven R, et al. Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: real-life data. Respir Med. 2010;104(9):1381–1385.
   PubMed Web of Science ®Google Scholar
• Rice JB, White AG, Scarpati LM, et al. Long-term systemic corticosteroid exposure: a systematic literature review. Clin Ther. 2017;39(11):2216–2229.
   PubMed Web of Science ®Google Scholar
• Volmer T, Effenberger T, Trautner C, et al. Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature. Eur Respir J. 2018;52:4.
   Web of Science ®Google Scholar
• Agusti A, Fabbri LM, Singh D, et al. Inhaled corticosteroids in COPD: friend or foe? Eur Respir J. 2018;52(6):1801219.
   Web of Science ®Google Scholar
• Qian CJ, Coulombe J, Suissa S, et al. Pneumonia risk in asthma patients using inhaled corticosteroids: a quasi-cohort study. Br J Clin Pharmacol. 2017;83(9):2077–2086.
   PubMed Web of Science ®Google Scholar
• Bansal V, Mangi MA, Johnson MM, et al. Inhaled corticosteroids and incident pneumonia in patients with asthma: systematic review and meta-analysis. Acta Med Acad. 2015;44(2):135–158.
   PubMedGoogle Scholar
• Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med. 2006;100(8):1307–1317.
   PubMed Web of Science ®Google Scholar
• Choi IS, Sim D-W, Kim S-H, et al. Adrenal insufficiency associated with long-term use of inhaled steroid in asthma. Ann Allergy Asthma Immunol. 2017;118(1):66–72.e1.
   PubMed Web of Science ®Google Scholar
• White M, Crisalida T, Li H, et al. Effects of long-term inhaled corticosteroids on adrenal function in patients with asthma. Ann Allergy Asthma Immunol. 2006;96(3):437–444.
   PubMed Web of Science ®Google Scholar
• Mahachoklertwattana P, Sudkronrayudh K, Direkwattanachai C, et al. Decreased cortisol response to insulin induced hypoglycaemia in asthmatics treated with inhaled fluticasone propionate. Arch Dis Child. 2004;89(11):1055–1058.
   PubMed Web of Science ®Google Scholar
• Fuhlbrigge AL, Kelly HW. Inhaled corticosteroids in children: effects on bone mineral density and growth. Lancet Respir Med. 2014;2(6):487–496.
   PubMed Web of Science ®Google Scholar
• Meibohm B, Hochhaus G, Rohatagi S, et al. Dependency of cortisol suppression on the administration time of inhaled corticosteroids. J Clin Pharmacol. 1997;37(8):704–710.
   PubMed Web of Science ®Google Scholar
• Zhang L, Prietsch SOM, Ducharme FM. Inhaled corticosteroids in children with persistent asthma: effects on growth. Cochrane Database Syst Rev. 2014;7:CD009471. DOI:10.1002/14651858.CD009471.pub2
   PubMed Web of Science ®Google Scholar
• Kowalski ML, Wojciechowski P, Dziewonska M, et al. Adrenal suppression by inhaled corticosteroids in patients with asthma: A systematic review and quantitative analysis. Allergy Asthma Proc. 2016;37(1):9–17.
   PubMed Web of Science ®Google Scholar
• Martinez FD, Vercelli D. Asthma. Lancet. 2013;382(9901):1360–1372.
   PubMed Web of Science ®Google Scholar
• Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18(5):716–725.
   PubMed Web of Science ®Google Scholar